Markus J. Cappel
2020
In 2020, Markus J. Cappel earned a total compensation of $2.2M as Chief Business Officer at ChemoCentryx, a 76% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,200 |
|---|---|
| Option Awards | $540,456 |
| Salary | $445,000 |
| Stock Awards | $1,085,547 |
| Other | $2,322 |
| Total | $2,233,525 |
Cappel received $1.1M in stock awards, accounting for 49% of the total pay in 2020.
Cappel also received $160.2K in non-equity incentive plan, $540.5K in option awards, $445K in salary and $2.3K in other compensation.
Rankings
In 2020, Markus J. Cappel's compensation ranked 5,026th out of 13,090 executives tracked by ExecPay. In other words, Cappel earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,026 out of 13,090 | 62nd |
Division Manufacturing | 2,053 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 819 out of 2,254 | 64th |
Industry group Drugs | 708 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 533 out of 1,459 | 64th |
Source: SEC filing on April 5, 2022.
Cappel's colleagues
We found two more compensation records of executives who worked with Markus J. Cappel at ChemoCentryx in 2020.